KEQU icon

Kewaunee Scientific

32.20 USD
+0.32
1.00%
At close Apr 22, 4:00 PM EDT
After hours
32.20
+0.00
0.00%
1 day
1.00%
5 days
0.16%
1 month
-28.38%
3 months
-47.23%
6 months
-2.07%
Year to date
-48.62%
1 year
-9.09%
5 years
193.53%
10 years
97.18%
 

About: Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

Employees: 1,006

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

111% more capital invested

Capital invested by funds: $36.1M [Q3] → $76.2M (+$40.1M) [Q4]

23% more funds holding

Funds holding: 35 [Q3] → 43 (+8) [Q4]

5.2% more ownership

Funds ownership: 37.76% [Q3] → 42.97% (+5.2%) [Q4]

9% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 11

Research analyst outlook

We haven’t received any recent analyst ratings for KEQU.

Financial journalist opinion

Positive
Zacks Investment Research
1 month ago
KEQU Reports Y/Y Earnings Decline in Q3 Despite Strong Sales Growth
Kewaunee Scientific's revenues rise 43.6% in Q3, but profits decline due to higher expenses and Nu Aire acquisition costs. Backlog hits $221.6 million.
KEQU Reports Y/Y Earnings Decline in Q3 Despite Strong Sales Growth
Neutral
PRNewsWire
1 month ago
Kewaunee Scientific Announces Amendment to Share Repurchase Program
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced an amendment to its existing share repurchase program.
Kewaunee Scientific Announces Amendment to Share Repurchase Program
Neutral
PRNewsWire
1 month ago
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2025.
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025
Neutral
PRNewsWire
1 month ago
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025
STATESVILLE, N.C. , Feb. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2025 financial results on Wednesday, March 12, 2025 after the close of trading.
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025
Positive
Seeking Alpha
4 months ago
Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report
Kewaunee Scientific manufactures laboratory furniture and equipment, a growing market driven by the need for advancements in healthcare. Since 2022, the company has focused on improving its margins through stop selling directly in some markets where the company had to focus on producing and selling. This has been reflected in the expansion of margins, but growth has been mid-single digit, and I think it can continue like this in the future.
Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report
Neutral
Zacks Investment Research
4 months ago
Kewaunee Scientific's Q2 Earnings Rise Y/Y Despite Sales Decline
KEQU reports fiscal Q2 earnings growth, driven by strong domestic demand and strategic acquisition of Nu Aire despite revenue challenges.
Kewaunee Scientific's Q2 Earnings Rise Y/Y Despite Sales Decline
Neutral
PRNewsWire
4 months ago
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
STATESVILLE, N.C. , Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2024.
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
Neutral
PRNewsWire
4 months ago
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025
STATESVILLE, N.C. , Nov. 27, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2025 financial results on Wednesday, December 11, 2024 after the close of trading.
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025
Neutral
PRNewsWire
5 months ago
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
STATESVILLE, N.C. , Nov. 1, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) Kewaunee Scientific Corporation ("Kewaunee"), a leader in laboratory furniture and technical product design and manufacturing, today announced the successful acquisition of Nu Aire, a Minneapolis-based company, for $55 million, subject to certain adjustments for debt, cash, transaction expenses, and net working capital.
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
Negative
Zacks Investment Research
6 months ago
Zacks Initiates Coverage of Kewaunee Scientific With Neutral Recommendation
Discover why Zacks rates KEQU as "Neutral," being the first on Wall Street to initiate the coverage of the stock. Explore KEQU's strong order backlog and stable domestic growth amid international challenges and competitive pressures in the laboratory furniture market.
Zacks Initiates Coverage of Kewaunee Scientific With Neutral Recommendation
Charts implemented using Lightweight Charts™